Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.4106
+0.0176 (4.48%)
Jun 9, 2025, 4:00 PM - Market closed
Leap Therapeutics Market Cap
Leap Therapeutics has a market cap or net worth of $17.02 million as of June 10, 2025. Its market cap has decreased by -82.28% in one year.
Market Cap
17.02M
Enterprise Value
-15.54M
1-Year Change
-82.28%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since January 25, 2017, Leap Therapeutics's market cap has decreased from $73.80M to $17.02M, a decrease of -76.94%. That is a compound annual growth rate of -16.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 6, 2025 | 16.30M | -85.21% |
Dec 31, 2024 | 110.20M | 3.96% |
Dec 29, 2023 | 106.00M | 137.67% |
Dec 30, 2022 | 44.60M | -84.42% |
Dec 31, 2021 | 286.20M | 113.26% |
Dec 31, 2020 | 134.20M | 395.20% |
Dec 31, 2019 | 27.10M | -7.82% |
Dec 31, 2018 | 29.40M | -49.83% |
Dec 29, 2017 | 58.60M | -20.60% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 697.84B |
Johnson & Johnson | 375.08B |
AbbVie | 334.34B |
Novo Nordisk | 332.47B |
UnitedHealth Group | 275.10B |
Abbott Laboratories | 233.03B |
Novartis AG | 231.17B |
AstraZeneca | 226.45B |